Skip to main content
Log in

Effects of calcium supplementation on circulating osteocalcin and glycated haemoglobin in older women

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

One year of calcium supplementation in older women led to modest reductions in total osteocalcin and undercarboxylated osteocalcin (ucOC), with no changes in muscle or fat mass, or glycated haemoglobin. Future studies should explore whether treatments with more profound effects of suppressing ucOC may lead to impaired glycaemic control.

Introduction

Total osteocalcin (TOC) is a marker of bone turnover, while its undercarboxylated form has beneficial effects on glucose metabolism in mice. This post hoc analysis of a randomised double-blind, placebo-controlled trial examined whether 1 year of calcium supplementation affected circulating TOC, undercarboxylated osteocalcin (ucOC) or glycated haemoglobin (HbA1c) in 1368 older community-dwelling women (mean age 75.2 ± 2.7 years).

Methods

Women enrolled in the Calcium Intake Fracture Outcome Study trial (1998–2003) were supplemented with 1.2 g/d of elemental calcium (in the form of calcium carbonate) or placebo. Circulating TOC, ucOC and HbA1c was measured at 1 year (1999).

Results

After 1 year of calcium supplementation, TOC and ucOC levels were 17% and 22% lower compared with placebo (mean 22.7 ± 9.1 vs. 27.3 ± 10.9 μg/L and 11.1 ± 4.9 vs. 13.0 ± 5.7 μg/L, both P < 0.001). Carboxylated osteocalcin/ucOC was 6% lower after calcium supplementation (P < 0.05). Despite this, no differences in HbA1c were observed (calcium, 5.2 ± 0.6 vs. placebo, 5.3 ± 0.8%; P = 0.08). Calcium supplementation did not affect BMI, whole body lean or fat mass. In exploratory analyses, total calcium (dietary and supplemental) was inversely related to TOC and ucOC, indicating calcium intake is an important dietary determinant of osteocalcin levels.

Conclusion

One year of calcium supplementation in older women led to modest reductions in TOC and ucOC, with no changes in muscle or fat mass, or HbA1c. Future studies should explore whether treatments with more profound effects of suppressing ucOC may lead to impaired glycaemic control.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Karsenty G (1998) Transcriptional regulation of osteoblast differentiation during development. Front Biosci 3:834–837

    Article  Google Scholar 

  2. Hauschka PV, Lian JB, Gallop PM (1975) Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci U S A 72:3925–3929

    Article  CAS  Google Scholar 

  3. Price PA, Otsuka AA, Poser JW, Kristaponis J, Raman N (1976) Characterization of a gamma-carboxyglutamic acid-containing protein from bone. Proc Natl Acad Sci U S A 73:1447–1451

    Article  CAS  Google Scholar 

  4. Brennan-Speranza TC, Conigrave AD (2015) Osteocalcin: an osteoblast-derived polypeptide hormone that modulates whole body energy metabolism. Calcif Tissue Int 96:1–10

    Article  CAS  Google Scholar 

  5. Hauschka PV, Lian JB, Cole DE, Gundberg CM (1989) Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 69:990–1047

    Article  CAS  Google Scholar 

  6. Ferron M, McKee MD, Levine RL, Ducy P, Karsenty G (2012) Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone 50:568–575

    Article  CAS  Google Scholar 

  7. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 130:456–469

    Article  CAS  Google Scholar 

  8. Ferron M, Hinoi E, Karsenty G, Ducy P (2008) Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A 105:5266–5270

    Article  CAS  Google Scholar 

  9. Shen H, Grimston S, Civitelli R, Thomopoulos S (2015) Deletion of connexin43 in osteoblasts/osteocytes leads to impaired muscle formation in mice. J Bone Min Res 30:596–605

    Article  CAS  Google Scholar 

  10. Lin X, Hanson E, Betik AC, Brennan-Speranza TC, Hayes A, Levinger I (2016) Hindlimb immobilization, but not castration, induces reduction of undercarboxylated osteocalcin associated with muscle atrophy in rats. J Bone Min Res 31:1967–1978

    Article  CAS  Google Scholar 

  11. Ferron M, Lacombe J (2014) Regulation of energy metabolism by the skeleton: osteocalcin and beyond. Arch Biochem Biophys 561:137–146

    Article  CAS  Google Scholar 

  12. Booth SL, Centi A, Smith SR, Gundberg C (2012) The role of osteocalcin in human glucose metabolism: marker or mediator? Nat Revs Endocrinol 9:43–55

    Article  Google Scholar 

  13. Bullo M, Moreno-Navarrete JM, Fernandez-Real JM, Salas-Salvado J (2012) Total and undercarboxylated osteocalcin predict changes in insulin sensitivity and beta cell function in elderly men at high cardiovascular risk. Am J Clin Nutr 95:249–255

    Article  CAS  Google Scholar 

  14. Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B (2009) Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 94:827–832

    Article  CAS  Google Scholar 

  15. Schafer AL, Sellmeyer DE, Schwartz AV, Rosen CJ, Vittinghoff E, Palermo L, Bilezikian JP, Shoback DM, Black DM (2011) Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). J Clin Endocrinol Metab 96:E1982–E1989

    Article  CAS  Google Scholar 

  16. Ngarmukos C, Chailurkit LO, Chanprasertyothin S, Hengprasith B, Sritara P, Ongphiphadhanakul B (2012) A reduced serum level of total osteocalcin in men predicts the development of diabetes in a long-term follow-up cohort. Clin Endocrinol 77:42–46

    Article  Google Scholar 

  17. Shea M, Dawson-Hughes B, Gundberg CM, Booth SL (2017) Reducing undercarboxylated osteocalcin with vitamin K supplementation does not promote lean tissue loss or fat gain over 3 years in older women and men: a randomized controlled trial. J Bone Min Res 32:243–249

    Article  CAS  Google Scholar 

  18. Schwartz AV, Schafer AL, Grey A, Vittinghoff E, Palermo L, Lui LYL, Wallace RB, Cummings SR, Black DM, Bauer DC, Reid IR (2013) Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and FREEDOM trials. J Bone Min Res 28:1348–1354

    Article  CAS  Google Scholar 

  19. Diaz-Lopez A, Bullo M, Juanola-Falgarona M, Martinez-Gonzalez MA, Estruch R, Covas MI, Aros F, Salas-Salvado J (2013) Reduced serum concentrations of carboxylated and undercarboxylated osteocalcin are associated with risk of developing type 2 diabetes mellitus in a high cardiovascular risk population: a nested case-control study. J Clin Endocrinol Metab 98:4524–4531

    Article  CAS  Google Scholar 

  20. Zhu K, Prince RL (2012) Calcium and bone. Clin Biochem 45:936–942

    Article  CAS  Google Scholar 

  21. Institute of Medicine (2011) Dietary reference intakes for calcium and vitamin D, Washington DC, USA

  22. National Health and Medical Research Council (Australia)., New Zealand. Ministry of Health., Australia. Dept. of Health and Ageing (2006) Nutrient reference values for Australia and New Zealand : including recommended dietary intakes. National Health and Medical Research Council, Canberra

    Google Scholar 

  23. Zhu K, Bruce D, Austin N, Devine A, Ebeling PR, Prince RL (2008) Randomized controlled trial of the effects of calcium with or without vitamin D on bone structure and bone-related chemistry in elderly women with vitamin D insufficiency. J Bone Min Res 23:1343–1348

    Article  CAS  Google Scholar 

  24. Prince RL, Devine A, Dhaliwal SS, Dick IM (2006) Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med 166:869–875

    Article  CAS  Google Scholar 

  25. Bruce DG, Devine A, Prince RL (2002) Recreational physical activity levels in healthy older women: the importance of fear of falling. J Am Geriatr Soc 50:84–89

    Article  Google Scholar 

  26. Britt H, Scahill S, Miller G (1997) ICPC PLUS for community health? A feasibility study. J Health Info Manage Assoc Aust 27:171

    CAS  Google Scholar 

  27. Gundberg CM, Lian JB, Gallop PM (1983) Measurements of gamma-carboxyglutamate and circulating osteocalcin in normal children and adults. Clin Chim Acta 128:1–828

    Article  CAS  Google Scholar 

  28. Hodge A, Patterson AJ, Brown WJ, Ireland P, Giles G (2000) The Anti Cancer Council of Victoria FFQ: relative validity of nutrient intakes compared with weighed food records in young to middle-aged women in a study of iron supplementation. Aust N Z J Public Health 24:576–583

    Article  CAS  Google Scholar 

  29. Ireland P, Jolley D, Giles G, O’Dea K, Powles J, Ritishauser I, Wahlqvist ML, Williams J (1994) Development of the Melbourne FFQ: a food frequency questionnaire for use in an Australian prospective study involving an ethnically diverse cohort. Asia Pac J Clin Nutr 3:19–31

    CAS  PubMed  Google Scholar 

  30. US Department of Agriculture ARS, and Nutrient Data Laboratory (2015) USDA National Nutrient Database for Standard Reference, Release 28

  31. Schurgers LJ, Vermeer C (2001) Determination of phylloquinone and menaquinones in food. Pathophysiol Haemost Thromb 30:298–307

    Article  Google Scholar 

  32. Manoury E, Jourdon K, Boyaval P, Fourcassie P (2013) Quantitative measurement of vitamin K 2 (menaquinones) in various fermented dairy products using a reliable high-performance liquid chromatography method. J Dairy Sci 96:1335–1346

    Article  CAS  Google Scholar 

  33. Lambert LJ, Challa AK, Niu A, Zhou L, Tucholski J, Johnson MS, Nagy TR, Eberhardt AW, Estep PN, Kesterson RA, Grams JM (2016) Increased trabecular bone and improved biomechanics in an osteocalcin-null rat model created by CRISPR/Cas9 technology. Dis Model Mech 9:1169–1179

    Article  CAS  Google Scholar 

  34. Levinger I, Jerums G, Stepto NK, Parker L, Serpiello FR, McConell GK, Anderson M, Hare DL, Byrnes E, Ebeling PR, Seeman E (2014) The effect of acute exercise on undercarboxylated osteocalcin and insulin sensitivity in obese men. J Bone Min Res 29:2571–2576

    Article  CAS  Google Scholar 

  35. Levinger I, Zebaze R, Jerums G, Hare DL, Selig S, Seeman E (2011) The effect of acute exercise on undercarboxylated osteocalcin in obese men. Osteoporos Int 22:1621–1626

    Article  CAS  Google Scholar 

  36. Liu DM, Guo XZ, Tong HJ, Tao B, Sun LH, Zhao HY, Ning G, Liu JM (2015) Association between osteocalcin and glucose metabolism: a meta-analysis. Osteoporos Int 26:2823–2833

    Article  CAS  Google Scholar 

  37. Levinger I, Seeman E, Jerums G et al (2016) Glucose-loading reduces bone remodeling in women and osteoblast function in vitro. Physiol Rep 4(3):e12700

    Article  Google Scholar 

Download references

Funding

The study was financially supported by a research grant from a Sir Charles Gairdner Hospital Research Advisory Committee, Healthway Health Promotion Foundation of Western Australia and by the project grants 254627, 303169 and 572604 from the National Health and Medical Research Council of Australia. The salary of Dr. Lewis is supported by a National Health and Medical Research Council of Australia Career Development Fellowship (ID: 1107474) and A/Prof Itamar Levinger is a Heart Foundation Future Leader Fellow (ID: 100040). None of the funding agencies had any role in the conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. R. Lewis.

Ethics declarations

The Human Ethics Committee of the University of Western Australia approved the study and written informed consents were obtained from all participants. Human ethics approval for the use of linked data for the project was provided by the Human Research Ethics Committee of the Western Australian Department of Health (DOHWA HREC), project number no. 2009/24.

Conflicts of interest

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Joshua R. Lewis, Tara C. Brennan-Speranza and Itamar Levinger are joint first authors.

Electronic supplementary material

ESM 1

(DOCX 140 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lewis, J.R., Brennan-Speranza, T.C., Levinger, I. et al. Effects of calcium supplementation on circulating osteocalcin and glycated haemoglobin in older women. Osteoporos Int 30, 2065–2072 (2019). https://doi.org/10.1007/s00198-019-05087-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-019-05087-3

Keywords

Navigation